Hybrid adaptive immunity to SARS-CoV-2 protects against breakthrough infection after COVID-19 vaccination in ALSPAC participants
Holly E. Baum, Marianna Santopaolo, Ore Francis, Emily Milowdowski, Katrina Entwistle, Elizabeth Oliver, Benjamin Hitchings, Divya Diamond, Amy C. Thomas, Ruth E. Mitchell, Milla Kibble, Kapil Gupta, Natalie Di Bartolo, Paul Klenerman, Anthony Brown, Begonia Morales-Aza, Jennifer Oliver, Imre Berger, View ORCID ProfileAsh M. Toye, Adam Finn, Anu Goenka, Andrew D. Davidson, Sue Ring, Lynn Molloy, Melanie Lewcock, Kate Northstone, Firona Roth, Nicholas J. Timpson, Linda Wooldridge, View ORCID ProfileAlice Halliday, Laura Rivino
doi: https://doi.org/10.1101/2024.06.14.24308948
Holly E. Baum
1School of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK
2Bristol Vaccine Centre, University of Bristol, Bristol, UK
Marianna Santopaolo
1School of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK
Ore Francis
1School of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK
3Bristol Veterinary School, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK
Emily Milowdowski
3Bristol Veterinary School, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK
Katrina Entwistle
3Bristol Veterinary School, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK
Elizabeth Oliver
1School of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK
2Bristol Vaccine Centre, University of Bristol, Bristol, UK
Benjamin Hitchings
1School of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK
2Bristol Vaccine Centre, University of Bristol, Bristol, UK
Divya Diamond
1School of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK
Amy C. Thomas
4Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
Ruth E. Mitchell
4Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
Milla Kibble
4Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
5Department of Applied Mathematics & Theoretical Physics, University of Cambridge, Cambridge, UK
6Department of Twin Research and Genetic Epidemiology, King’s College London, London, UK
Kapil Gupta
7School of Biochemistry, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK
Natalie Di Bartolo
7School of Biochemistry, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK
Paul Klenerman
8Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, Oxford, UK
Anthony Brown
9Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK
Begonia Morales-Aza
1School of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK
2Bristol Vaccine Centre, University of Bristol, Bristol, UK
Jennifer Oliver
2Bristol Vaccine Centre, University of Bristol, Bristol, UK
4Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
Imre Berger
7School of Biochemistry, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK
Ash M. Toye
7School of Biochemistry, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK
Adam Finn
1School of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK
2Bristol Vaccine Centre, University of Bristol, Bristol, UK
4Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
10Department of Paediatric Immunology and Infectious Diseases, Bristol Royal Hospital for Children, Bristol, UK
Anu Goenka
1School of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK
2Bristol Vaccine Centre, University of Bristol, Bristol, UK
4Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
10Department of Paediatric Immunology and Infectious Diseases, Bristol Royal Hospital for Children, Bristol, UK
Andrew D. Davidson
1School of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK
Sue Ring
4Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
Lynn Molloy
4Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
Melanie Lewcock
4Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
Kate Northstone
4Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
Firona Roth
4Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
Nicholas J. Timpson
4Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
11MRC Integrative Epidemiology Unit at University of Bristol, Bristol, UK
Linda Wooldridge
3Bristol Veterinary School, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK
Alice Halliday
1School of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK
2Bristol Vaccine Centre, University of Bristol, Bristol, UK
Laura Rivino
1School of Cellular and Molecular Medicine, Faculty of Health and Life Sciences, University of Bristol, Bristol, UK
- Supplementary Information[supplements/308948_file02.pdf]
Posted June 15, 2024.
Hybrid adaptive immunity to SARS-CoV-2 protects against breakthrough infection after COVID-19 vaccination in ALSPAC participants
Holly E. Baum, Marianna Santopaolo, Ore Francis, Emily Milowdowski, Katrina Entwistle, Elizabeth Oliver, Benjamin Hitchings, Divya Diamond, Amy C. Thomas, Ruth E. Mitchell, Milla Kibble, Kapil Gupta, Natalie Di Bartolo, Paul Klenerman, Anthony Brown, Begonia Morales-Aza, Jennifer Oliver, Imre Berger, Ash M. Toye, Adam Finn, Anu Goenka, Andrew D. Davidson, Sue Ring, Lynn Molloy, Melanie Lewcock, Kate Northstone, Firona Roth, Nicholas J. Timpson, Linda Wooldridge, Alice Halliday, Laura Rivino
medRxiv 2024.06.14.24308948; doi: https://doi.org/10.1101/2024.06.14.24308948
Hybrid adaptive immunity to SARS-CoV-2 protects against breakthrough infection after COVID-19 vaccination in ALSPAC participants
Holly E. Baum, Marianna Santopaolo, Ore Francis, Emily Milowdowski, Katrina Entwistle, Elizabeth Oliver, Benjamin Hitchings, Divya Diamond, Amy C. Thomas, Ruth E. Mitchell, Milla Kibble, Kapil Gupta, Natalie Di Bartolo, Paul Klenerman, Anthony Brown, Begonia Morales-Aza, Jennifer Oliver, Imre Berger, Ash M. Toye, Adam Finn, Anu Goenka, Andrew D. Davidson, Sue Ring, Lynn Molloy, Melanie Lewcock, Kate Northstone, Firona Roth, Nicholas J. Timpson, Linda Wooldridge, Alice Halliday, Laura Rivino
medRxiv 2024.06.14.24308948; doi: https://doi.org/10.1101/2024.06.14.24308948
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2855)
- Dermatology (244)
- Emergency Medicine (430)
- Epidemiology (12563)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4437)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2851)
- Health Policy (1049)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4196)
- Nursing (222)
- Nutrition (617)
- Oncology (2204)
- Ophthalmology (624)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (269)
- Palliative Medicine (82)
- Pathology (486)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6784)
- Radiology and Imaging (1490)
- Respiratory Medicine (900)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)